Hamostaseologie 2022; 42(03): 174-179
DOI: 10.1055/a-1528-0513
Original Article

Increasing Use of Anticoagulants in Germany and Its Impact on Hospitalization for Tooth Extraction

Olga von Beckerath
1   Clinic of Vascular Medicine, HELIOS Klinik Krefeld, Krefeld, Germany
,
Knut Kröger
1   Clinic of Vascular Medicine, HELIOS Klinik Krefeld, Krefeld, Germany
,
Frans Santosa
2   Faculty of Medicine, Universitas Pembangunan Nasional Veteran Jakarta, Jakarta, Indonesia
,
Ayat Nasef
1   Clinic of Vascular Medicine, HELIOS Klinik Krefeld, Krefeld, Germany
,
Bernd Kowall
3   Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany
,
Andreas Stang
3   Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany
4   Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States
› Institutsangaben

Abstract

Objectives This article aimed to compare nationwide time trends of oral anticoagulant prescriptions with the time trend of hospitalization for tooth extraction (TE) in Germany from 2006 through 2017.

Patients and Methods We derived the annual number of hospital admissions for TE from the Nationwide Hospital Referral File of the Federal Bureau of Statistics and defined daily doses (DDD) of prescribed anticoagulants in outpatients from reports of the drug information system of the statutory health insurance.

Results From 2005 to 2017, annual oral anticoagulation (OAC) treatment rates increased by 143.7%. In 2017, direct oral anticoagulants (DOACs) represented 57.1% of all OAC treatments. The number of cases hospitalized for TE increased by 28.0 only. From all the cases hospitalized for TE in Germany in 2006, 14.2% had a documented history of long-term use of OACs. This proportion increased to 19.6% in 2017. Age-standardized hospitalization rates for all TE cases with long-term use of OACs increased from 6.6 in 2006 to 10.5 cases per 100,000 person-years in 2014 and remained almost unchanged thereafter.

Conclusion Our comparison showed that the large increase in OAC treatment rates in general from 2006 to 2017 had only a small impact on hospitalized TE cases with long-term use of OAC which flattens since 2014.



Publikationsverlauf

Eingereicht: 02. März 2021

Angenommen: 11. Juni 2021

Artikel online veröffentlicht:
23. November 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Müller M, Schlittler F, Schaller B, Nagler M, Exadaktylos AK, Sauter TC. Characteristics, treatment and outcome of bleeding after tooth extraction in patients on DOAC and phenprocoumon compared to non-anticoagulated patients-a retrospective study of emergency department consultations. Clin Oral Investig 2019; 23 (05) 2273-2278
  • 2 Bensi C, Belli S, Paradiso D, Lomurno G. Postoperative bleeding risk of direct oral anticoagulants after oral surgery procedures: a systematic review and meta-analysis. Int J Oral Maxillofac Surg 2018; 47 (07) 923-932
  • 3 Lanau N, Mareque J, Giner L, Zabalza M. Direct oral anticoagulants and its implications in dentistry. A review of literature. J Clin Exp Dent 2017; 9 (11) e1346-e1354
  • 4 Connolly SJ, Ezekowitz MD, Yusuf S. et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361 (12) 1139-1151
  • 5 Granger CB, Alexander JH, McMurray JJ. et al; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365 (11) 981-992
  • 6 Patel MR, Mahaffey KW, Garg J. et al; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365 (10) 883-891
  • 7 Kirchhof P, Lip GY, Van Gelder IC. et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference. Thromb Haemost 2011; 106 (06) 1012-1019
  • 8 Lip GY, Huber K, Andreotti F. et al; Consensus Document of European Society of Cardiology Working Group on Thrombosis. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary – a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2010; 31 (11) 1311-1318
  • 9 van Es N, Coppens M, Schulman S, Middeldorp S, Büller HR. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood 2014; 124 (12) 1968-1975
  • 10 Lim HY, Nandurkar H, Ho P. Direct oral anticoagulants and the paradigm shift in the management of venous thromboembolism. Semin Thromb Hemost 2018; 44 (03) 261-266
  • 11 Bleckwenn M, Dinkel K, Weckbecker K, Mücke M. Einsatz der Neuen oralen Antikoagulanzien in Hausarztpraxen. Z Allg Med 2016; 92: 28-32
  • 12 Alwafi H, Wei L, Naser AY. et al. Trends in oral anticoagulant prescribing in individuals with type 2 diabetes mellitus: a population-based study in the UK. BMJ Open 2020; 10 (05) e034573
  • 13 Berton F, Costantinides F, Rizzo R. et al. Should we fear direct oral anticoagulants more than vitamin K antagonists in simple single tooth extraction? A prospective comparative study. Clin Oral Investig 2019; 23 (08) 3183-3192
  • 14 Stang A, Merrill RM, Kuss O. Nationwide rates of conversion from laparoscopic or vaginal hysterectomy to open abdominal hysterectomy in Germany. Eur J Epidemiol 2011; 26 (02) 125-133
  • 15 Stang A, Kääb-Sanyal V, Hense HW, Becker N, Kuss O. Effect of mammography screening on surgical treatment for breast cancer: a nationwide analysis of hospitalization rates in Germany 2005-2009. Eur J Epidemiol 2013; 28 (08) 689-696
  • 16 Guelker JE, Ilousis D, Kröger K, Santosa F, Kowall B, Stang A. Increasing use of anticoagulants in Germany and its impact on hospitalization for gastrointestinal bleeding. Thromb Res 2019; 181: 135-140
  • 17 von Beckerath O, Paulitschek AM, Kröger K, Kowall B, Santosa F, Stang A. Increasing use of anticoagulants in Germany and its impact on hospitalization rates for genitourinary bleeding. J Thromb Thrombolysis 2020; 49 (04) 533-539
  • 18 Sumanth KN, Prashanti E, Aggarwal H. et al. Interventions for treating post-extraction bleeding. Cochrane Database Syst Rev 2016; 6 (06) CD011930
  • 19 Bacci C, Maglione M, Favero L. et al. Management of dental extraction in patients undergoing anticoagulant treatment. Results from a large, multicentre, prospective, case-control study. Thromb Haemost 2010; 104 (05) 972-975
  • 20 Nathwani S, Wanis C. Novel oral anticoagulants and exodontia: the evidence. Br Dent J 2017; 222 (08) 623-628
  • 21 NICE. Clinical Knowledge Summaries: Anticoagulation–Oral–Management. Accessed May 2017 at: https://cks.nice.org.uk/anticoagulation-oral
  • 22 Costantinides F, Rizzo R, Pascazio L, Maglione M. Managing patients taking novel oral anticoagulants (NOAs) in dentistry: a discussion paper on clinical implications. BMC Oral Health 2016; 16: 5
  • 23 Mauprivez C, Khonsari RH, Razouk O, Goudot P, Lesclous P, Descroix V. Management of dental extraction in patients undergoing anticoagulant oral direct treatment: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol 2016; 122 (05) e146-e155
  • 24 Lababidi E, Breik O, Savage J, Engelbrecht H, Kumar R, Crossley CW. Assessing an oral surgery specific protocol for patients on direct oral anticoagulants: a retrospective controlled cohort study. Int J Oral Maxillofac Surg 2018; 47 (07) 940-946